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Objective: Cranial nerve injury involves loss of central neural cells in the brain stem and surrounding support
matrix, leading to severe functional impairment. Therapeutically targeting cellular replacement and enhancing
structural support may promote neural regeneration. We examined the combinatorial effect of neural precursor
cells (NPC) and self assembling peptide (SAP) administration on nerve regeneration.
Methods: Nerve injury was induced by clip compression of the rodent spinal cord. SAPs were injected immediately
into the injured cord and NPCs at 2 weeks post-injury. Behavioral analysis was done weekly and rats were sacrificed
at 11 weeks post injury. LFB-H&E staining was done on cord tissue to assess cavitation volume. Motor evoked
potentials (MEP) were measured at week 11 to assess nerve conduction and Kaplan meier curves were created to
compare survival estimates.
Results: NPCs and SAPs were distributed both caudal and rostral to the injury site. Behavioral analysis showed that
SAP + NPC transplantation significantly improved locomotor score p <0.03) and enhanced survival (log rank test,
p = 0.008) compared to control. SAP + NPC treatment also improved nerve conduction velocity (p = 0.008) but did
not affect cavitation volume (p = 0.73).
Conclusion: Combinatorial NPC and SAP injection into injured nerve tissue may enhance neural repair and
regeneration.Introduction
Peripheral nerve injury in the head and neck region may
result in significant morbidity for patients [1-3]. Ad-
vancement in nerve regeneration has been met with var-
ied success, partly related to the various mechanisms of
nerve injury such as stretch, laceration, compression,
resulting in different degrees of structural disruption and
cellular loss [4-7].
Self assembling peptides (SAPs) are bioengineered
peptides which assemble into nanofibers in situ, forming
a scaffold potentially linking damaged nerve segments.
SAPs have been shown to enhance axonal regeneration
and functional recovery in spinal cord injury models ei-
ther alone [8], or in combination with a RhoA inhibitor
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reproduction in any medium, provided the or[10]. K2(QL)6 K2 is an SAP composed of gutamine and
leucine amino acids which assembles into a β-sheet con-
formation and is soluble at a pH of 7, very close to
physiologic pH. Unlike implanted solid scaffolds, QL6
can be injected into damaged nerve tissue as a liquid,
potentially reducing the occurrence of iatrogenic mech-
anical injury.
Adult neural precursor cells (NPCs) have properties of
self renewal and multipotency [11-13]. When harvested
from the subventricular zone of the forebrain, it was
shown that about 50% of NPCs transplanted into the
subacute injured spinal cord tissue differentiated into
premature or mature oligodendrocytes [11]. NPC-
derived oligodendrocytes enhanced myelination of axons
and improved functional recovery. Neurobehavioral re-
covery of chronically injured spinal cord tissue was also
improved with NPC transplantation when chondroitia-
nase ABC was administered via infusion prior to trans-
plantation [14].
We propose that the combinatorial treatment of SAPs
and NPCs may enhance recovery after spinal cord injurytd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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enhancing meylination by repopulating oligodendrocytes
derived from NPCs. Given the similarities in molecular
and anatomic features of the peripheral nervous system
(PNS) and central nervous system (CNS), it is tempting
to speculate that the therapeutic strategies employed in
this study would also be applicable in peripheral nerve
regeneration. PNS and CNS employ similar extracellular
matrix components involved in development and a large
fraction of the PNS cytoplasmic bulk is found within
the CNS [15]. Furthermore, both oligodendrocytes and
Schwann cells assemble and maintain myelin to promote
axonal potential speeds. Our results indicated that the
combinatorial treatment of SAP +NPC improved nerve
conduction velocity, enhanced functional recovery, and
increased the probability of survival after spinal cord in-
jury. However, we did not see a reduction in cavitation
or residual volume, potentially due to a survival bias
from a high mortality rate in the control group.
Methods
22 female Wister rats were used in this study (250–300
gm, Charles River Laboratories, Wilmington, MA). SAP +
NPC and control groups both had 11 animals. The
University Health Network animal care committee ap-
proved all experimental protocols in accordance to pol-
icies as per the Canadian Council of Animal Care Guide
to the Care and Use of Experimental Animals.
Spinal cord injury
Animals were put under anaesthesia using isoflurane
and a 3:1 mixture of oxygen to nitrogen. The surgical
site was sterilized using betadine and 70% isopropyl al-
cohol. T6-T7 was landmarked using the prominent spine
of T2 and an incision was made from T4 – T9. Soft tis-
sue was dissected down to the lamina of T6-T7 and
laminectomy was performed at T6-T7 exposing the
spinal cord. Spinal cord injury was induced using a 35
gm aneurysm clip passed around the cord and snapped
closed for 1 minute. This aneurysm clip model of SCI
has been well established [16,17].
SAP-QL6 injection
The primary investigator conducting surgical proce-
dures was blinded to SAP-QL6 and control injection
(SAP-QL6: 1% concentration, control: saline). Immedi-
ately following spinal cord injury, a Hamilton syringe
with a glass capillary needle was used to inject a total
of 10 µL of SAP solution or control into the injured
nerve tissue at a rate of 0.5 µl/min (5 µl injected 2 mm
rostral to injury site and 5 µl injected 2 mm caudal to
injury site). The needle was left in nerve tissue for an
additional minute after each injection to promote diffu-
sion of SAP-QL6.NPC transplantation
NPC isolation and culture was conducted as per
Karimi-Abdolrezaee et al. [11]. Rats with T6-7 injury
and SAP-QL6 or control injection were pre-treated
with immunomodulating agents, minocycline and cyclo-
sporine A, for 24–36 hours pre-operatively. These animals
were then put under anaesthesia and the surgical site was
reopened, exposing T6-7 cord tissue. NPCs prepared
from passage 3–4 neurospheres were mechanically dis-
associated into single cells and diluted using growth
medium (5 × 104/µl) after testing for viability with try-
pan blue. Control used for NPC transplantation was
growth medium. NPCs or control was transplanted into
nerve tissue at two points both 2 mm rostrally and
caudally to injury site (4 injection sites total) using a
Hamilton syringe attached to a glass capillary with total
injection volume of 8 µl. To enhance survival of NPCs,
an intrathecal catheter was inserted rostral to the injury
site and passed caudally past NPC transplantation site.
This catheter was attached to an osmotic pump (model
1007D, 0.5 µl/h; Alzat, Cupertino, CA) filled with plate-
let derived growth factor-AA (1 ug/100 µl, Sigma),
basic fibroblast growth factor (3 µg/100 µl, Sigma), and
epidermal growth factor (3 µg/100 µl) in a solution
containing artificial cerebrospinal fluid, bovine serum
albumin (100 µg/ml), and gentamycine (50 µg/ml). The
osmotic pump was designed to promote release of
these factors over 7 days, thereby enhancing NPC sur-
vival. The surgical site was then closed and animals
were all treated with minocycline for 1 week and cyclo-
sporine A for the duration of experiments.
Neurobehavioral testing
To test neurobehavioral recovery after nerve injury, the
Basso, Beattie, and Bresnahan (BBB) open field loco-
motor score was determined by two independent
blinded assessors weekly from weeks 1 to 11 post-injury.
BBB scoring system is a 21 point scale testing hindlimb
recovery through assessment of joint movement, step
ability, coordination, and trunk stability. Weekly results
were averaged for left and right hindlimbs.
Electrophysiology
To determine whether SAP +NPC improved nerve con-
duction characteristics, motor evoked potentials (MEP)
were assessed in vivo. At week 11 post-injury, a blinded in-
vestigator put animals under light sedation using isoflur-
ane and 2 stainless steel subdermal needle electrodes were
placed into the biceps femoris. A square pulse (2 mA
stimulus of 0.1 ms at 0.13 Hz) was applied to the midline
cervical spinal cord and recordings were measured using
Keypoint Portable (Dantec Biomed, Denmark). Amplitude
was measured between positive and negative peaks and la-
tency was calculated from the initiation of pulse stimulus
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each animal was calculated based on average tracing of
200 sweeps.
H&E processing and measurements
Transcardiac perfusion was performed at 11 weeks post-
injury using 4% paraformaldehyde in 0.1 M PBS. Spinal
cord tissue with a length of about 2 cm centered at the
injury site was extracted and embedded. Serial cross sec-
tioning of the cord was done at 30 micron thickness
using a cryostat (Leica CM3050S). Sections were stained
with hematoxylin-eosin (HE) and myelin selective pig-
ment luxol fast blue (LFB). Measurements of total cord
and cavity volume were assessed by a blinded investiga-
tor using Cavalieri Probe (Steroinvestigator software).
Statistics
Data was assessed using SPSS. Comparison of BBB loco-
motor scores was done using 2-way ANOVA with post-
hoc Bonferroni test. MEP scores and cavitation volume
were compared with Student’s t-test. Comparisons of
survival between treatment and control groups were
done using Kaplan Meier curves.
Results
Biodistribution of SAP and NPC in injured spinal cord
tissue
To examine the biodistribution of SAPs and NPCs along
the injured nerve tissue, we injected SAP-QL6 labelled
with FITC immediately post-injury and transplanted
NPCs labelled with DSred 2 weeks post-injury. Animals
were perfused at day 15 after NPC transplantation. Lon-
gitudinal section of the injured spinal cord showed pres-
ence of NPCs and SAPs both caudal and rostral to the
site of injury (Figure 1).
SAP + NPC treatment enhances neurobehavioral recovery
To examine the effect of SAP + NPC treatment on
neurologic functional recovery, two independent blindedFigure 1 Biodistribution of SAP and NPC along injured spinal cord. SA
NPC labelled with DSred were transplanted 2 weeks after injury. DAPI was
post-injury. SAP and NPC were found rostral and caudal to injured cord segobservers assessed BBB open field locomotor scores
from week 1 to 11 post-injury. Both SAP + NPC and
control group demonstrated improvements in BBB
locomotor scores over time (Figure 2). SAP + NPC
treatment resulted in higher mean BBB locomotor
scores up to 10 weeks post-injury. At 10 to 11 weeks,
there was no difference between the 2 groups in BBB
score. Using two way ANOVA, we found a statistically
significant difference in BBB locomotor score favouring
SAP +NPC treatment group (p < 0.03). Scores for SAP +
NPC and control peaked at a mean of 7, suggesting that
this may be the limit of functional recovery given the
degree of injury.
SAP + NPC treatment demonstrated improved overall
survival
Poor motor and automatic function following spinal
cord injury results in an increased risk of mortality [18].
It was observed that a large number of control animals
were dying secondary to UTIs relative to SAP +NPC
group. To determine whether SAP + NPC treatment re-
sulted in an increase in overall survival, we plotted a
Kaplan-Meier curve comparing survival between SAP +
NPC and control groups (Figure 3). There was a statisti-
cally significant difference in log rank test between
the two groups with 36% of control (4/11) and 91% of
SAP +NPC (10/11) treated animals surviving to week 11
(p = 0.008). Two animals died independent of a UTI.
One animal in the SAP + NPC group had to be sacrificed
due to neuropathic pain, and 1 animal in the control
group died due to an intra-abdominal abscess, possibly
secondary to intraperitoneal minocycline injection.
SAP + NPC treatment did not result in less cavitation
To determine whether SAP +NPC treatment was corre-
lated with a reduction in cavitation, injured cord tissue
was stained with LFB-HE at 11 weeks post-injury. A
blinded assessor then assessed whole cord and cavity
volume. There was no statistically significant differenceP labelled with FITC was injected immediately after spinal cord injury.
used to stain cell nuclei blue. Spinal cord was perfused at 4 weeks
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Figure 2 BBB locomotor score of SAP + NPC treatment and
control. BBB locomotor scores were assessed by 2 independent
reviewers from week 1 – 11 post-injury. Both control and SAP + NPC
groups exhibited improvements in score over time. SAP + NPC
group showed higher mean scores up to week 10. There was a
significant difference in scores between the two groups (2-way
































Figure 4 Cavitation volume percentage. Cord tissue was
collected at week 11 post-injury and cross sections stained with
LFB-HE. Percentage cavitation was calculated based on cavity
volume divided by total cord volume for each animal. There was no
statistical difference between SAP + NPC and treatment groups in
percentage cavitation (p = 0.73).
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ume (8.14% vs 10.66%) by Student’s t-test (p = 0.73)
(Figure 4).
SAP + NPC treatment improved motor evoked potentials
NPCs have been shown to differentiate into oligodendro-
cytes and increase myelination of axons. To determine
whether nerve conduction was enhanced by SAP +NPC
treatment, MEPs were assessed at 11 weeks post-jury.
SAP +NPC treatment resulted in decreased latency com-
pared to control (20.68 +/− 5.27 vs 30.53 +/− 7.54), indi-
cating a faster velocity of conduction (p = 0.008).
Discussion
Damage to cranial nerves, whether through a disease
process or by iatrogenic injury, is uncommon but is as-
sociated with significant morbidity [1-3]. In the headFigure 3 Kaplan-Meier curve of survival estimates. Log rank test
was significant between the two groups (p < 0.008). Percentage of
animals surviving at week 11 was 36% (4/11) for control group and
91% (10/11) for SAP + NPC treatment group.and neck, injury to the facial nerve as well as CN9-12 can
result in an array of debilitating conditions ranging from
facial deformity to swallowing difficulties, dysphonia, to
airway compromise. Multiple injury-associated defects,
such as loss of structural and cellular components, may
impede the success of single modality treatments aimed at
nerve regeneration. As such, multimodality strategies tar-
geted at repopulating myelinating cells and reconstructing
structural support through bioengineered scaffolds may
enhance nerve regeneration. In this study, we found that
the combinatorial treatment of SAP-QL6 and NPCs en-
hanced neurobehavioral recovery, increased conduction
velocity, and improved survival.
The injury model used in this study employed a modi-
fied aneurysm clip applied to the spinal cord at T6-7
resulting in a contusion, compression, and stretch injury.
This mechanism may be similar to iatrogenic nerve in-
jury as compression and stretch are two of the main
mechanisms of peripheral nerve injury [7]. Although the
spinal cord was used as a nerve injury model, the simi-
larities between the PNS and CNS suggest that the
structural support afforded by SAP-QL6 injection and
potential for myelination by NPC transplantation could
benefit PNS regeneration, such as cranial nerve palsies
in otolaryngology. It has been shown that NPCs, when
embedded in a collagen gel and wrapped around an in-
jured segment of sciatic peripheral nerve, differentiate
into Schwann-like supporting cells and increased the
number and diameter of myelinated fibers [19]. On the
other hand, transplantation of Schwann cells into the in-
jured spinal cord was found to enhance meylination and
improve hindlimb function [20].
SAP +NPC treatment improved BBB locomotor score
and decreased conduction latency, which, taken together,
demonstrate a benefit of the combinatorial treatment
in neurological functional recovery. Interestingly, BBB
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NPC treatment at 10 and 11 weeks post-injury. It could
be that SAP +NPC treatment improved the rate of re-
covery, but did not affect overall functional recovery.
However, SAP + NPC treated animals exhibited lower
MEP latency at week 11 post-injury, suggesting that BBB
locomotor score may not account for subtle changes in
function. SAP + NPC treated animals scored in the range
of 6 to 8 and an increase in score from 8 to 9 is the dif-
ference between coordinated full hindlimb movement
and weight bearing, which would require significantly
more complex recovery. Finally the lack of difference in
BBB scores at week 10 and 11 may be due to a survivor
bias, as there were significantly more deaths in the con-
trol group (Figure 3).
The high mortality rate in the control group was likely
secondary to an increased risk of urinary tract infections
(UTIs). Spinal cord injury at level T6-7 results in a
neurogenic bladder and all but two deaths in this study
were attributed to UTIs. The risk of sepsis and death
secondary to UTI was likely increased as all animals
were given immunosuppressive drugs for the entire dur-
ation of the experiments. UTI was diagnosed based on a
combination of cloudy discharge, foul smelling urine,
and lethargy. Any suspected UTI was treated empirically
with amoxicillin. Given that the internal and external
sphincter of the bladder are under autonomic and volun-
tary control respectively, the significantly lower risk of
mortality with SAP +NPC treatment suggests autonomic
and/or somatic recovery of bladder function was im-
proved in the treatment group compared to control.
In this study, we did not find a significant difference in
cavity volume between SAP +NPC treatment and con-
trol groups. It could be that there was a survival bias in
favour of the control group, as animals with more cavita-
tion were likely to have a higher risk of mortality. Even
so, the improvements in BBB locomotor score and MEP
latency suggest that a reduction in cavity volume was
not necessary for functional recovery.
Conclusion
SAP +NPC treatment was found to improve BBB loco-
motor scores, nerve conduction velocity, and survival.
Taken together, SAP +NPC may improve functional re-
covery after nerve injury. Given the similarities between
the PNS and CNS, this combinatorial treatment strategy
may hold promise for regeneration of the PNS. Future
work will build on this pilot study comparing SAP +
NPC treatment to SAP and NPC treatment alone, as
well as using this treatment strategy for a peripheral
nerve injury model, such as the facial or sciatic nerve.
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